|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of credit allowance | ||||||||||||||||||||
| Unbilled accounts receivable | ||||||||||||||||||||
| Stock subscription receivables | ||||||||||||||||||||
| Other accounts receivable | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Equipment-in-process | ||||||||||||||||||||
| Intangible asset, net | ||||||||||||||||||||
| Right-of-use asset, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Right-of-use assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Long-Term Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued contract loss provision | ||||||||||||||||||||
| Accrued bonuses | ||||||||||||||||||||
| Accrued bonuses | ||||||||||||||||||||
| Accrued contract loss provision | ||||||||||||||||||||
| Accrued legal settlement | ||||||||||||||||||||
| Unearned revenue | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| Secured promissory note | ||||||||||||||||||||
| Financing liability | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Unearned revenue, less current portion | ||||||||||||||||||||
| Long-Term Liabilities: | ||||||||||||||||||||
| Unearned revenue, less current portion | ||||||||||||||||||||
| Convertible notes, net of discount | ||||||||||||||||||||
| Note payable, less current portion | ||||||||||||||||||||
| Financing liability | ||||||||||||||||||||
| Operating lease liabilities, less current portion | ||||||||||||||||||||
| Total Long-Term Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred Stock: 50,000,000; 1,000,000 Designated as Convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common stock: 1,000,000,000 common shares authorized, par value $0.0001 per share, 17,718,161 and 17,143,771 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...
